Targeted aspartoacylase gene therapy reverts Canavan disease
Crossref DOI link: https://doi.org/10.1038/nrneurol.2017.170
Published Online: 2017-11-24
Published Print: 2018-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Starling, Shimona
Text and Data Mining valid from 2017-11-24
Article History
First Online: 24 November 2017